C4 Therapeutics, Inc. ( CCCC) - Key Metrics
CCCC Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.05 | -$0.18 | -$0.01 | -$0.01 |
| 2026Q1 | $0.05 | -$0.20 | -$0.24 | -$0.24 |
| 2025Q4 | $0.09 | -$0.18 | -$0.19 | -$0.19 |
| 2025Q3 | $0.15 | -$0.44 | -$0.43 | -$0.44 |
| 2025Q1 | $0.09 | -$0.37 | -$0.17 | -$0.17 |
CCCC Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -6.49 |
| 2026Q1 | 0% | -3.29 |
| 2025Q4 | 0% | -2.65 |
| 2025Q3 | 0% | -1.26 |
| 2025Q1 | 0% | -0.97 |
CCCC
Price: $2.76
52 week price:
Earnings Per Share: -0.91 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 914600
Market Capitalization: 330.6 million